Riverview Health Centre
Winnipeg, Manitoba, R3L 2P4, Canada
NCT Number: NCT05507190
The main objective of this pilot study is to evaluate the impact of a self-management intervention using wearable biometric technology on post-COVID-19 syndrome. In addition, this pilot-study will provide information regarding validity, feasibility, patient compliance and satisfaction, valuable for the design of a future large-scale study.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Winnipeg, Manitoba, R3L 2P4, Canada
This pilot-study uses a one-group before-after design. Subjects: a convenience sample of 20 adults 18 years and older in the Winnipeg Health Region with a post-COVID-19 infection (≥ 3 months since acute infection) complaining of mild to severe persistent respiratory symptoms. Intervention: using the participants' initial assessment, personal characteristics, main complaints/needs and goals, the therapist will adjust the exercise plan and personalize the recommendations (e.g. maximum heart rate) as well as instruct the patients about safety precautions (how to pace themselves, when to seek professional or emergency care). Participants will be encouraged to wear the smart shirt as much as they want during the 6 weeks (29), but at a minimum of 1-hour a day (M-F) including while performing the recommended exercises (30-45 min/3 times a week). They should self-monitor their biometric values trying to reach/stay within the target values while wearing the shirt using Hexoskin app installed on an iPad provided by the research team or on the participants' personal device if preferred. Patients will also complete an online survey reporting symptoms intensity and activities completed, 3 times a week (over 6 weeks). Participants would be able to contact the research assistant overseeing the intervention at any time of the study if they have questions or concerns (text message or email). Otherwise, they will receive a follow-up phone call every week or if a significant change in their biometrical data is identified.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intervention: using the participants' initial assessment, personal characteristics, main complaints/needs and goals, the therapist will adjust the exercise plan and personalize the recommendations (e.g. maximum heart rate) as well as instruct the patients about safety precautions (how to pace themselves, when to seek professional or emergency care). Participants will be encouraged to wear the smart shirt as much as they want during the 6 weeks (29), but at a minimum of 1-hour a day (M-F) including while performing the recommended exercises (30-45 min/3 times a week). They should self-monitor their biometric values trying to reach/stay within the target values while wearing the shirt using Hexoskin app installed on an iPad provided by the research team or on the participants' personal device if preferred.
Time frame: 6 weeks
It will be assessed using a SpiroBank Smart F/V multi parameter spirometer (MIR) at pre-post intervention and once a week in between to monitor changes. This portable spirometer, which is MDSAP approved and complaint with ATS/ERS guidelines, connects automatically via Bluetooth to an iOS & Android compatible App (MIR Spirobank). It provides real time feedback through messages and animation on smartphone, to improve personal compliance during the test. The app can generate test results PDF printout with information regarding 19 parameters of lung capacity.
Time frame: 6 weeks
Modified Borg Scale (0 "best" to 10 "worse dyspnea") will be used to assess dyspnea.
Time frame: 6 weeks
Fatigue severity scale (0 -7 "more fatigue") will be used to measure the severity of fatigue.
Time frame: 6 weeks
DePaul Symptoms Questionnaire short form (DSQ-SF) (0 "not present" - 4 "very severe")
Time frame: 6 weeks
EuroQol five-dimensional questionnaire (0 "worse health" to 100 "best health")
Time frame: 6 weeks
Orthostatic Stress Test (Postural transitions)
Time frame: 6 weeks
The 6-min walk test (6 MWT) and the one-minute sit-to-stand test
Time frame: 6 weeks
Participants will be ask to rate their symptoms from 0-10 using an online form (base on the baseline symptoms)
Time frame: 6 week
Participants will complete a short summary with questions regarding their satisfaction with the study
University of Manitoba
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07722000
COVID-19, Chronic Disease
Banī Suwayf, Beni Suweif Governorate, Egypt
View Trial DetailsNCT05876377
COVID-19, Chronic Disease
New York, United States
View Trial DetailsNCT05920616
COVID Long-Haul, COVID-19
Baltimore, Maryland, United States
View Trial DetailsNCT07560059
COVID-19, Chronic Disease
Algiers, El Biar, Algeria
View Trial Details